Education
About Us
Working with TipRanks
Follow Us
Maravai Lifesciences Holdings (MRVI)
NASDAQ:MRVI
RESEARCH TOOLSreports
MRVI Analyst Ratings
Moderate Buy
4 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MRVI Stock 12 Month Forecast
Average Price Target
$4.25
▲(103.35%Upside)
| Highest Price Target$7.00 | Average Price Target$4.25 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$2
Hold
-4.31%
Downside
Reiterated
06/14/25
The overall stock score of 51 reflects significant financial and valuation challenges, with negative profitability and a concerning P/E ratio. Technical analysis shows bearish trends, while the earnings call highlighted mixed results, with revenue growth but ongoing profitability and geopolitical risks.
Craig-Hallum
―
Buy
―
Reiterated
06/10/25
Wells Fargo
$4
Buy
91.39%
Upside
Reiterated
06/09/25
William Blair
―
Hold
―
Reiterated
06/09/25
Morgan Stanley
$5
Hold
139.23%
Upside
Reiterated
05/21/25
Robert W. Baird
$3→$2
Hold
-4.31%
Downside
Reiterated
05/13/25
Stifel Nicolaus
$5
Buy
139.23%
Upside
Reiterated
05/13/25
UBS
$8→$2.5
Hold
19.62%
Upside
Reiterated
03/21/25
Jefferies
$10
Buy
378.47%
Upside
Reiterated
03/18/25
Bank of America Securities
$9→$8
Buy
282.78%
Upside
Reiterated
03/03/25
Guggenheim
―
Hold
―
Initiated
12/19/24
Goldman Sachs
―
Sell
―
Downgraded
12/05/24
MongoDB (MDB) PT Raised to $375 at KeyBancinvchannel between footer and predictions You May Also Be Interested In MongoDB (MDB) PT Raised to $380 at Baird Ascentage Pharma Group (6855:HK) PT Raised to HK$52 at Citi Goldman Sachs Downgrades Maravai LifeScience Holdings Inc. (MRVI ) to Sell Ad: news_below:adblade
Wolfe Research
―
Hold
―
Initiated
11/14/24
Deutsche Bank
$10
Buy
378.47%
Upside
Assigned
08/09/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$2
Hold
-4.31%
Downside
Reiterated
06/14/25
The overall stock score of 51 reflects significant financial and valuation challenges, with negative profitability and a concerning P/E ratio. Technical analysis shows bearish trends, while the earnings call highlighted mixed results, with revenue growth but ongoing profitability and geopolitical risks.
Craig-Hallum
―
Buy
―
Reiterated
06/10/25
Wells Fargo
$4
Buy
91.39%
Upside
Reiterated
06/09/25
William Blair
―
Hold
―
Reiterated
06/09/25
Morgan Stanley
$5
Hold
139.23%
Upside
Reiterated
05/21/25
Robert W. Baird
$3→$2
Hold
-4.31%
Downside
Reiterated
05/13/25
Stifel Nicolaus
$5
Buy
139.23%
Upside
Reiterated
05/13/25
UBS
$8→$2.5
Hold
19.62%
Upside
Reiterated
03/21/25
Jefferies
$10
Buy
378.47%
Upside
Reiterated
03/18/25
Bank of America Securities
$9→$8
Buy
282.78%
Upside
Reiterated
03/03/25
Guggenheim
―
Hold
―
Initiated
12/19/24
Goldman Sachs
―
Sell
―
Downgraded
12/05/24
MongoDB (MDB) PT Raised to $375 at KeyBancinvchannel between footer and predictions You May Also Be Interested In MongoDB (MDB) PT Raised to $380 at Baird Ascentage Pharma Group (6855:HK) PT Raised to HK$52 at Citi Goldman Sachs Downgrades Maravai LifeScience Holdings Inc. (MRVI ) to Sell Ad: news_below:adblade
Wolfe Research
―
Hold
―
Initiated
11/14/24
Deutsche Bank
$10
Buy
378.47%
Upside
Assigned
08/09/24
Best Analysts Covering Maravai Lifesciences Holdings
1 Month
xxx
Success Rate
13/24 ratings generated profit
Average Return
-0.12%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 54.17% of your transactions generating a profit, with an average return of -0.12% per trade.
3 Months
xxx
Success Rate
5/15 ratings generated profit
Average Return
-9.11%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -9.11% per trade.
1 Year
Success Rate
3/15 ratings generated profit
Average Return
-28.50%
reiterated a buy rating last month
Copying Daniel Arias's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -28.50% per trade.
2 Years
xxx
Success Rate
1/10 ratings generated profit
Average Return
-50.44%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 10.00% of your transactions generating a profit, with an average return of -50.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MRVI Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
3
9
11
13
8
Buy
4
5
4
3
2
Hold
3
6
6
7
4
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
20
21
23
14
Each month's total comprises the sum of three months' worth of ratings.
MRVI Financial Forecast
MRVI Stock Forecast FAQ
What is MRVI’s average 12-month price target, according to analysts?
Based on analyst ratings, Maravai Lifesciences Holdings’s 12-month average price target is 4.25.
What is MRVI’s upside potential, based on the analysts’ average price target?
Maravai Lifesciences Holdings has 103.35% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MRVI a Buy, Sell or Hold?
Maravai Lifesciences Holdings has a consensus rating of Moderate Buy which is based on 4 buy ratings, 4 hold ratings and 0 sell ratings.
What is Maravai Lifesciences Holdings’s price target?
The average price target for Maravai Lifesciences Holdings is 4.25. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $7.00 ,the lowest forecast is $2.00. The average price target represents 103.35% Increase from the current price of $2.09.
The highest analyst price target is $7.00 ,the lowest forecast is $2.00. The average price target represents 103.35% Increase from the current price of $2.09.
What do analysts say about Maravai Lifesciences Holdings?
Maravai Lifesciences Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of MRVI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.